Efficacy assessment

SL Sijie Li
XX Xiurong Xing
LW Lanjing Wang
JX Jiali Xu
CR Changhong Ren
YL Yalin Li
JW Jing Wang
ZL Zhi Liu
HZ Heng Zhao
WZ Wenbo Zhao
XJ Xunming Ji
ask Ask a question
Favorite

The primary efficacy endpoint of this study was the rate of MACCEs within 3 months after enrollment, which comprises death from all causes, unstable angina, AMI, AIS, and transient ischemic attack.

The secondary efficacy endpoints of this study included (1) the proportion of subjects who achieved functional independence (defined as modified Rankin Scale [mRS] ≤ 2 points) at 3-month follow-up; and (2) changes in mRS scores.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A